[NEW YORK, USA – May 12th, 2025] – The animal vaccine industry is undergoing an unprecedented transformation, according to a new 360-page ClearView Market Insights report. The market is set to grow at a 12.1% CAGR to USD 24.3 billion by 2030, driven by breakthroughs in genetic vaccines.
Request Sample @ https://clearviewmarketinsights.com/report-details/global-animal-vaccines-market/
Key Industry Shifts
- mRNA Vaccine Dominance
- Zoetis's Canine Innovations:
- Lyme disease prevention in 96% of cases
- Melanoma vaccine extends survival by 2.7 years
- Boehringer's ASF Solution:
- Single-dose protection for 300M pigs annually
- Zoonotic Defense Systems
- USDA's H5N1 Program:
- New vaccines target 10+ emerging strains
- Nipah Virus Preparedness:
- Fast-tracked vaccine prevents $20B/year spillover risk
- Economic Impacts
- Swine Industry Savings:
- ASF vaccines could prevent $120B in global losses
- Dairy Productivity:
- Mastitis vaccines boost yields by 15%
Executive Insights
- Dr. Mike McFarland, Zoetis CMO:
"We're bringing human oncology advances to pets—with better outcomes." - Dr. Eva Maria Binder, Boehringer CSO:
"Our saRNA platform can update vaccines faster than viruses mutate."
Global Health Impact
- Rabies Elimination:
- AU program aims for zero human deaths by 2030
- One Health Integration:
- 40% of human pandemic prevention now starts with animal vaccines
Future Projections
- 2026: Edible plant vaccines for poultry enter trials
- 2028: Needle-free nanoparticle vaccines dominate livestock sector
- 2030: AI-designed antigens create universal flu vaccines
For more insights, visit https://clearviewmarketinsights.com/
About ClearView Market Insights Analytics
ClearView Market Insights Analytics is a global leader in industrial technology research, offering actionable insights across more than 100 laser market segments.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369
